2024

1. Masuda M, Nakagawa R, Kondo T. Harnessing the Potential of Reverse-Phase Protein Array Technology: Advancing Precision Oncology Strategies. Cancer Sci. In press

2021

1. Kondo T. Current status and future outlook for patient-derived cancer models from a rare cancer research perspective. Cancer Sci. 2021 Mar;112(3):953-961. doi: 10.1111/cas.14669. Epub 2021 Feb 6. PMID: 32986888; PMCID: PMC7935796. [PubMed]（外部リンク）

2020

1. Noguchi R, Sin Y, Kondo T. Gel electrophoresis for phosphorylated proteins: a brief introduction. J Electrophoresis. J Electrophoresis. 2020 64(1):13-17［PubMed］(外部リンク)
2. Kondo T. Current status and future outlook for patient-derived cancer models from a rare cancer research perspective. Cancer Sci. 2020 Sep 28. doi: 10.1111/cas.14669. Epub ahead of print. PMID: 32986888. [PubMed]（外部リンク）
3. Kondo T. Current status and perspectives of patient-derived rare cancer models. Hum Cell. 2020 Oct;33(4):919-929. doi: 10.1007/s13577-020-00391-1. Epub 2020 Jun 14. PMID: 32537685. [PubMed]（外部リンク）
4. Kondo T. Necessity of guidelines for publication of patient-derived cancer models. Ann Transl Med. 2020 Mar;8(5):158. doi: 10.21037/atm.2019.12.144. PMID:32309306; PMCID: PMC7154464. [PubMed]（外部リンク）

2019

1. Hattori E, Kondo T. Current status of cancer proteogenomics: a brief introduction. J Electrophoresis. 2019 63:33-37 [J-Stage]（外部リンク）
2. Kondo T. Cancer biomarker development and two-dimensional difference gel electrophoresis (2D-DIGE). Biochim Biophys Acta Proteins Proteom. 2019 Jan;1867(1):2-8. doi: 10.1016/j.bbapap.2018.07.002. Epub 2018 Jul 7. Review. PubMed PMID: 30392560. ［PubMed］(外部リンク)

2018

1. Kondo T. Mass Spectrometry and Proteomics 2018: the Mass Spectrometry Society of Japan, Japanese Proteomics Society, and Asia-Oceania Human Proteome Organization. Expert Rev Proteomics. 2018 Oct;15(10):777-779. doi:10.1080/14789450.2018.1525297. Epub 2018 Sep 21. PMID: 30223682. [PubMed]（外部リンク）
2. Kondo T. Current Status of Proteomics in Ewing's Sarcoma. Proteomics Clin Appl. 2019 May;13(3):e1700130. doi: 10.1002/prca.201700130. Epub 2018 Aug 23. Review. PubMed PMID: 29992772. [PubMed]（外部リンク） 

2017

1. Kondo T. Current status of proteomics of soft tissue sarcomas. Expert Rev Proteomics. 2017 Dec;14(12):1131-1140. doi: 10.1080/14789450.2017.1394190. Epub 2017 Oct 25. Review. PMID: 29039718. [PubMed]（外部リンク）

2016

1. Pan X, Yoshida A, Kawai A, Kondo T. Current status of publicly available sarcoma cell lines for use in proteomic studies. Expert Rev Proteomics. 2016;13(2):227-40. doi: 10.1586/14789450.2016.1132166. Epub 2016 Jan 11. Review. PMID: 26653594. [PubMed]（外部リンク）
2. Uemura N, Kondo T. Current status of proteomics of esophageal carcinoma. Expert Rev Proteomics. 2016 Nov;13(11):1029-1040. doi: 10.1080/14789450.2016.1242418. Epub 2016 Oct 8. PubMed PMID: 27678273. [PubMed]（外部リンク）

2015

1. Kikuta K, Morioka H, Kawai A, Kondo T. Global protein-expression profiling for reclassification of malignant fibrous histiocytoma. Biochim Biophys Acta. 2015 Jun;1854(6):696-701. doi: 10.1016/j.bbapap.2014.08.012. Epub 2014 Aug 28.Review. PMID: 25173742. [PubMed]（外部リンク）
2. Uemura N, Kondo T. Current advances in esophageal cancer proteomics. Biochim Biophys Acta. 2015 Jun;1854(6):687-95. doi: 10.1016/j.bbapap.2014.09.011. Epub 2014 Sep 16.Review. PMID: 25233958. [PubMed]（外部リンク）

2014

1. Kondo T, Kawai A. A Proteomic approach for the development of sarcoma biomarkers. EuPA Open Proteomics 2014;4時12分1-8. [ScienceDirect]（外部リンク）
2. Uemura N, Kondo T. Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer. World J Gastrointest Pathophysiol. 2014 Aug 15;5(3):322-34. doi: 10.4291/wjgp.v5.i3.322. Review. PMID: 25133032; PMCID: PMC4133529. [PubMed]（外部リンク）
3. Kondo T. Inconvenient truth: cancer biomarker development by using proteomics. Biochim Biophys Acta. 2014 May;1844(5):861-5. doi: 10.1016/j.bbapap.2013.07.009. Epub 2013 Jul 27. Review. PMID: 23896458. [PubMed]（外部リンク）
4. Kondo T. Casting doubt on the traditional approach of cancer biomarker discovery through proteomics. Expert Rev Proteomics. 2014 Feb;11(1):9-12. doi: 10.1586/14789450.2014.871496. Epub 2013 Dec 18.Review. PMID: 24351084. [PubMed]（外部リンク）

2013

1. Kondo T, Suehara Y, Kikuta K, Kubota D, Tajima T, Mukaihara K, Ichikawa H, Kawai A. Proteomic approach toward personalized sarcoma treatment: Lessons from prognostic biomarker discovery in gastrointestinal stromal tumor. Proteomics Clin Appl. 2013;7(1-2):70-8. doi: 10.1002/prca.201200085. Review. PMID: 23281253. [PubMed]（外部リンク）
2. Suehara Y, Kohsaka S, Kubota D, Mukaihara K, Akaike K, Mineki R, Fujimura T, Kaneko K, Ladanyi M, Saito T, Kondo T. Proteomic Technologies to Develop Biomarkers and Functional Analyses. J Proteomics Bioinform. 2013, S3. doi: 10.4172/jpb.S3-001 [LongDom]（外部リンク）

2012

1. Vegvari A, Kondo T, Marshall J. G. Clinical proteomics. Int J Proteomics. 2012;2012:641491. doi: 10.1155/2012/641491. Epub 2012 Aug 15. PMID: 22934184; PMCID: PMC3426226. [PubMed]（外部リンク）
2. Suehara Y, Kubota D, Kikuta K, Kaneko K, Kawai A, Kondo T. Discovery of biomarkers for osteosarcoma by proteomics approaches. Sarcoma. 2012;2012時42分5636. Epub 2012 Nov 21. PMID: 23226966; PMCID: PMC3512344. [PubMed]（外部リンク）
3. Kondo T, Kubota D, Kawai A. Application of proteomics to soft tissue sarcomas. Int J Proteomics. 2012;2012:876401. doi: 10.1155/2012/876401. Epub 2012 Jun 19. PMID: 22778956; PMCID: PMC3388341. [PubMed]（外部リンク）

2011

1. Misek D. E, Kondo T, Duncan M. W. Proteomics-based disease biomarkers. Int J Proteomics. 2011;2011:894618. doi: 10.1155/2011/894618. Epub 2011 Oct 30. PMID: 22110951; PMCID: PMC3205713. [PubMed]（外部リンク）
2. Kato H, Nishimura T, Ikeda N, Yamada T, Kondo T, Saijo N, Nishio K, Fujimoto J, Nomura M, Oda Y, Lindmark B, Maniwa J, Hibino H, Unno M, Ito T, Sawa Y, Tojo H, Egawa S, Edula G, Lopez M, Wigmore M, Inase N, Yoshizawa Y, Nomura F, Marko-Varga G. Developments for a growing Japanese patient population: facilitating new technologies for future health care. J Proteomics. 2011 May 16;74(6):759-64. doi: 10.1016/j.jprot.2010.12.006. Epub 2010 Dec 22. PMID: 21184850. [PubMed]（外部リンク）

2010

1. Kondo T. Cancer proteome-expression database: Genome Medicine Database of Japan Proteomics. Expert Rev Proteomics. 2010;7(1):21-7. doi: 10.1586/epr.09.87. Review. PMID: 20121473. [PubMed]（外部リンク）

2008

1. Kondo T. Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE. BMB Rep. 2008;Sep 30;41(9):626-34. Review. PMID: 18823585. [PubMed]（外部リンク）
2. Kondo T. Cancer proteomics for biomarker development. J Proteomics Bioinform. 2008;1(9):477-84.[LongDom]（外部リンク）
3. Kawai A, Kondo T, Suehara Y, Kikuta K, Hirohashi S. Global protein-expression analysis of bone and soft tissue sarcomas. Clin Orthop Relat Res. 2008 Sep;466(9):2099-106. doi: 10.1007/s11999-008-0330-4. Epub 2008 Jun 6. PMID: 18535868; PMCID: PMC2493021. [PubMed]（外部リンク）